Literature DB >> 17158940

Inhibition of gene expression and growth by antisense peptide nucleic acids in a multiresistant beta-lactamase-producing Klebsiella pneumoniae strain.

Prathiba Kurupati1, Kevin Shyong Wei Tan, Gamini Kumarasinghe, Chit Laa Poh.   

Abstract

Klebsiella pneumoniae causes common and severe hospital- and community-acquired infections with a high incidence of multidrug resistance. The emergence and spread of beta-lactamase-producing K. pneumoniae strains highlight the need to develop new therapeutic strategies. In this study, we developed antisense peptide nucleic acids (PNAs) conjugated to the (KFF)(3)K peptide and investigated whether they could mediate gene-specific antisense effects in K. pneumoniae. No outer membrane permeabilization was observed with antisense PNAs when used alone. Antisense peptide-PNAs targeted at two essential genes, gyrA and ompA, were found to be growth inhibitory at concentrations of 20 muM and 40 muM, respectively. Mismatched antisense peptide-PNAs with sequence variations of the gyrA and ompA genes when used as controls were not growth inhibitory. Bactericidal effects exerted by peptide-anti-gyrA PNA and peptide-anti-ompA PNA on cells were observed within 6 h of treatment. The antisense peptide-PNAs specifically inhibited expression of DNA gyrase subunit A and OmpA from the respective targeted genes in a dose-dependent manner. Both antisense peptide-PNAs cured IMR90 cell cultures that were infected with K. pneumoniae (10(4) CFU) in a dose-dependent manner without any noticeable toxicity to the human cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17158940      PMCID: PMC1803136          DOI: 10.1128/AAC.00709-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

Review 1.  Outer membrane protein A (OmpA): a new pathogen-associated molecular pattern that interacts with antigen presenting cells-impact on vaccine strategies.

Authors:  Pascale Jeannin; Giovanni Magistrelli; Liliane Goetsch; Jean-Francois Haeuw; Nathalie Thieblemont; Jean-Yves Bonnefoy; Yves Delneste
Journal:  Vaccine       Date:  2002-12-19       Impact factor: 3.641

2.  Inhibition of Staphylococcus aureus gene expression and growth using antisense peptide nucleic acids.

Authors:  Natalia Nekhotiaeva; Satish Kumar Awasthi; Peter E Nielsen; Liam Good
Journal:  Mol Ther       Date:  2004-10       Impact factor: 11.454

3.  PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules.

Authors:  M Egholm; O Buchardt; L Christensen; C Behrens; S M Freier; D A Driver; R H Berg; S K Kim; B Norden; P E Nielsen
Journal:  Nature       Date:  1993-10-07       Impact factor: 49.962

4.  Cell permeabilization and uptake of antisense peptide-peptide nucleic acid (PNA) into Escherichia coli.

Authors:  Magdalena Eriksson; Peter E Nielsen; Liam Good
Journal:  J Biol Chem       Date:  2001-12-05       Impact factor: 5.157

5.  Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae.

Authors:  H Yigit; A M Queenan; G J Anderson; A Domenech-Sanchez; J W Biddle; C D Steward; S Alberti; K Bush; F C Tenover
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

Review 6.  Extended-spectrum beta-lactamases: a clinical update.

Authors:  David L Paterson; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

7.  Bactericidal antisense effects of peptide-PNA conjugates.

Authors:  L Good; S K Awasthi; R Dryselius; O Larsson; P E Nielsen
Journal:  Nat Biotechnol       Date:  2001-04       Impact factor: 54.908

8.  Group of peptides that act synergistically with hydrophobic antibiotics against gram-negative enteric bacteria.

Authors:  M Vaara; M Porro
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

9.  Outer membrane permeability in Pseudomonas aeruginosa: comparison of a wild-type with an antibiotic-supersusceptible mutant.

Authors:  B L Angus; A M Carey; D A Caron; A M Kropinski; R E Hancock
Journal:  Antimicrob Agents Chemother       Date:  1982-02       Impact factor: 5.191

10.  Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide.

Authors:  P E Nielsen; M Egholm; R H Berg; O Buchardt
Journal:  Science       Date:  1991-12-06       Impact factor: 47.728

View more
  32 in total

1.  Inhibition of aac(6')-Ib-mediated amikacin resistance by nuclease-resistant external guide sequences in bacteria.

Authors:  Alfonso J C Soler Bistué; Fernando A Martín; Nicolás Vozza; Hongphuc Ha; Jonathan C Joaquín; Angeles Zorreguieta; Marcelo E Tolmasky
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-28       Impact factor: 11.205

2.  An Introduction to Fluorescence in situ Hybridization in Microorganisms.

Authors:  Carina Almeida; Nuno F Azevedo
Journal:  Methods Mol Biol       Date:  2021

3.  Antimicrobial activity of antisense peptide-peptide nucleic acid conjugates against non-typeable Haemophilus influenzae in planktonic and biofilm forms.

Authors:  Taketo Otsuka; Aimee L Brauer; Charmaine Kirkham; Erin K Sully; Melinda M Pettigrew; Yong Kong; Bruce L Geller; Timothy F Murphy
Journal:  J Antimicrob Chemother       Date:  2016-09-28       Impact factor: 5.790

4.  High-density functional-RNA arrays as a versatile platform for studying RNA-based interactions.

Authors:  Jack O Phillips; Louise E Butt; Charlotte A Henderson; Martin Devonshire; Jess Healy; Stuart J Conway; Nicolas Locker; Andrew R Pickford; Helen A Vincent; Anastasia J Callaghan
Journal:  Nucleic Acids Res       Date:  2018-08-21       Impact factor: 16.971

5.  Antisense phosphorodiamidate morpholino oligomers targeted to an essential gene inhibit Burkholderia cepacia complex.

Authors:  David E Greenberg; Kimberly R Marshall-Batty; Lauren R Brinster; Kol A Zarember; Pamela A Shaw; Brett L Mellbye; Patrick L Iversen; Steven M Holland; Bruce L Geller
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

Review 6.  Advances in therapeutic bacterial antisense biotechnology.

Authors:  John P Hegarty; David B Stewart
Journal:  Appl Microbiol Biotechnol       Date:  2017-12-05       Impact factor: 4.813

7.  Morpholino oligomers tested in vitro, in biofilm and in vivo against multidrug-resistant Klebsiella pneumoniae.

Authors:  Bruce L Geller; Lixin Li; Fabian Martinez; Erin Sully; Carolyn R Sturge; Seth M Daly; Christine Pybus; David E Greenberg
Journal:  J Antimicrob Chemother       Date:  2018-06-01       Impact factor: 5.790

8.  Potent antibacterial antisense peptide-peptide nucleic acid conjugates against Pseudomonas aeruginosa.

Authors:  Anubrata Ghosal; Peter E Nielsen
Journal:  Nucleic Acid Ther       Date:  2012-10       Impact factor: 5.486

9.  Inhibition of gene expression and growth of multidrug-resistant Acinetobacter baumannii by antisense peptide nucleic acids.

Authors:  Huijuan Wang; Yunyan He; Yun Xia; Lipeng Wang; Shumei Liang
Journal:  Mol Biol Rep       Date:  2014-08-05       Impact factor: 2.316

10.  Targeting essential genes in Salmonella enterica serovar typhimurium with antisense peptide nucleic acid.

Authors:  Muhammad A Soofi; Mohamed N Seleem
Journal:  Antimicrob Agents Chemother       Date:  2012-09-24       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.